M3 receptor is involved in the effect of penehyclidine hydrochloride reduced endothelial injury in LPS-stimulated human pulmonary microvascular endothelial cell.

Qinghong Yuan,Fei Xiao,Qiangsheng Liu,Fei Zheng,Shiwen Shen,Qianwen He,Kai Chen,Yanlin Wang,Zongze Zhang,Jia Zhan
DOI: https://doi.org/10.1016/j.pupt.2017.11.007
IF: 3.282
2018-01-01
Pulmonary Pharmacology & Therapeutics
Abstract:LPS has been recently shown to induce muscarinic acetylcholine 3 receptor (M3 receptor) expression and penehyclidine hydrochloride (PHC) is an anticholinergic drug which could block the expression of M3 receptor. PHC has been demonstrated to perform protective effect on cell injury. This study is to investigate whether the effect of PHC on microvascular endothelial injury is related to its inhibition of M3 receptor or not.
What problem does this paper attempt to address?